Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients

Intensive Care Medicine

Volumn 39, Issue 7, 2013, Pages 1253-1261

  Routsi, Christina ^a   Pratikaki, Maria ^a,b   Platsouka, Evangelia ^b,d   Sotiropoulou, Christina ^a   Papas, Vasileios ^a   Pitsiolis, Theodoros ^a   Tsakris, Athanassios ^c   Nanas, Serafeim ^a   Roussos, Charis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d IASO GENERAL HOSPITAL   (Greece)

Author keywords

Bacteremia; Blood stream infections; Carbapenem resistance; Critically ill patients; Gram negative bacilli

Indexed keywords

CARBAPENEM; COLISTIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE SEPSIS; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; VENTILATOR ASSOCIATED PNEUMONIA;

BACTEREMIA; BETA-LACTAM RESISTANCE; CARBAPENEMS; CASE-CONTROL STUDIES; CROSS INFECTION; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GREECE; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84879090700     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-013-2914-z     Document Type: Article

References (35)

1. Gaynes R, Edwards JR, The National Nosocomial Infections Surveillance System (2005) Overview of Nosocomial Infections caused by Gram-negative bacilli. Clin Infect Dis 41:848-854
2. Clark NM, Patterson J, Lynch JP (2003) Antimicrobial resistance among gram negative organisms in the intensive care unit. Curr Opin Crit Care 9:413-423
3. Paterson DL (2006) Resistance in gram-negative bacteria: enterobacteriaceae. Am J Infect Control 34:S20-S28
4. Flournoy DJ, Reinert RL, Bell-Dixon C et al (2000) Increasing antimicrobial resistance in Gram-negative bacilli isolated from patients in intensive care units. Am J Infect Control 28:244-250
5. Kollef MH, Fraser VJ (2001) Antibiotic resistance in the intensive care unit. Ann Intern Med 134:298-314
6. Jones RN, Phaller MA (1998) Bacterial resistance: a worldwide problem. Diagn Microbiol Infect Dis 31:379-388
7. Fridkin SK (2001) Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 29:N64-N68
8. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos G, Vatopoulos A, Gniadkowski M, Toth A, Pfeifer Y, Jarlier V, Carmeli Y; CNSE Working Group 2010) Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euroserveill 15(46). pii 19711
9. Pratikaki M, Platsouka E, Sotiropoulou C, Vassilakopoulos T, Paniara O, Roussos C, Routsi C (2009) Risk factors for and influence of bloodstream infections on mortality: a 1-year prospective study in a Greek intensive care unit. Epidemiol Infect 137:727-735
10. Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Nanas S, Markaki V, Vrettou C, Paniara O, Giamarellou H, Roussos C (2010) Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection 38:173-180
11. Kaye KS, Harris AD, Samore M, Carmeli Y (2005) The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol 26:346-351
12. Knaus WA, Draper EA, Wagner DP, Zimmerman JA (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818-829
13. Vincent JL, De Mendoka A, Cantraine F et al (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units. Results of a multicenter, prospective study. Crit Care Med 26:1793-1800
14. st-century approach. Clin Infect Dis 34:1564-1567
15. Harris AD, Samore M, Lipsitch Kaye KS, Perencevich E, Carmeli Y (2002) Control-group selection importance in studies with antimicrobial resistance: examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli. Clin Infect Dis 34:1558-1563
16. Harris AD, Karchmer TB, Carmeli Y, Samore MH (2001) Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 32:1055-1061
17. Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29:530-538
18. Garner JS, Jarvis WR, Emori TG et al (1998) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128-140
19. Clinical and Laboratory Standards Institute (2012) Performance standards for antimicrobial susceptibility testing. Twenty-second Informational Supplement M100 - S22. 32(3)
20. Kritsotakis EI, Tsioutis C, Roumbelaki M, Christidou A, Gikas A (2011) Antibiotic use and the risk of carbapenem-resistant extended-spectrum-β lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J Antimicrob Chemother 66:1383-1391
21. Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann M-C (2002) Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 34:340-345
22. Niedreman MS (2001) Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med 29(Suppl):N114-N120
23. Gaynes R (1997) The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect Dis Clin North Am 11:757-765
24. Loeffler JM, Garbino J, Lew D et al (2003) Antibiotic consumption, bacterial resistance and their correlations in a Swiss university hospital and its adult intensive care units. Scand J Infect Dis 35:843-850
25. Friedrich LV, White RL, Bosso JA (1999) Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes. Clin Infect Dis 28:1017-1024
26. Hsueh PR, Chen WH, Luh KT (2005) Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 26:463-472
27. Akinci E, Colpan A, Bodur H, Balaban N, Erbay A (2005) Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections. J Hosp Infect 59:317-323
28. Troillet N, Samore MH, Carmeli Y (1997) Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis 25:1094-1098
29. Kwak YG, Choi SH, Choo EJ, Chung JW, Jeong JW, Kim NJ, Woo JH, Ryu J, Kim YS (2005) Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist 11:165-169
30. Ong DSY, Jongerden IP, Buiting AG, Leverstein-van Hall MA, Speelberg B, Kesecioglu J, Bonten MJM (2011) Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units. Crit Care Med 39:2458-2463
31. Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A (2007) Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case-control study. J Antimicrobial Chemother 60:1124-1130
32. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y (2008) Predictors of carbapenem-resistant Klebsiella pneumonia acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52:1028. doi: 10.1128/AAC01020-07
33. Kraniotaki E, Manganelli R, Platsouka E, Grossato A, Paniara O, Palu G (2006) Molecular investigation of an outbreak of multidrug-resistant Acinetobacter baumannii, with characterization of class 1 integrons. Int J Antimicrob Agents 28:193-199
34. Mentzelopoulos S, Pratikaki M, Platsouka E, Kraniotaki H, Zervakis D et al (2007) Prolonged use of carbapenems and collistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa. Intensive Care Med 33:1524-1532
35. Raymond DP, Pelletier SJ, Crabtree TD, Evans HL, Pruett TL, Sawyer RG (2003) Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients. Crit Care Med 31:1035-1104